Clinical Trial Update: Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission

View source ↗

Summary

This completed clinical trial evaluated resistance to methotrexate in patients with acute lymphoblastic leukemia who were in relapse or remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Status: COMPLETED